Introduced:
May 23, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
3
Actions
7
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
May 23, 2025
Referred to the House Committee on Energy and Commerce.
Actions (3)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
May 23, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: Intro-H
May 23, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1000
May 23, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (7)
(D-TX)
Sep 16, 2025
Sep 16, 2025
(R-MD)
Jul 29, 2025
Jul 29, 2025
(R-IA)
Jun 25, 2025
Jun 25, 2025
(R-MO)
Jun 11, 2025
Jun 11, 2025
(R-AZ)
Jun 10, 2025
Jun 10, 2025
(R-FL)
Jun 10, 2025
Jun 10, 2025
(R-UT)
Jun 10, 2025
Jun 10, 2025
Full Bill Text
Length: 1,724 characters
Version: Introduced in House
Version Date: May 23, 2025
Last Updated: Nov 11, 2025 6:10 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3595 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 3595
To amend the Public Health Service Act to provide for the disclosure of
certain records relating to substance use disorder medications to State
prescription drug monitoring programs, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 23, 2025
Mr. Kennedy of Utah introduced the following bill; which was referred
to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to provide for the disclosure of
certain records relating to substance use disorder medications to State
prescription drug monitoring programs, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[H.R. 3595 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 3595
To amend the Public Health Service Act to provide for the disclosure of
certain records relating to substance use disorder medications to State
prescription drug monitoring programs, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 23, 2025
Mr. Kennedy of Utah introduced the following bill; which was referred
to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to provide for the disclosure of
certain records relating to substance use disorder medications to State
prescription drug monitoring programs, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Safe Prescribing Through Reporting
Act of 2025''.
SEC. 2.
DISORDER MEDICATIONS TO STATE PRESCRIPTION DRUG
MONITORING PROGRAMS.
MONITORING PROGRAMS.
Section 543
(b)
(2) of the Public Health Service Act (42 U.
(b)
(2) of the Public Health Service Act (42 U.S.C.
290dd-2
(b)
(2) ) is amended by adding at the end the following:
``
(E) To the applicable prescription drug
monitoring program of a State if--
``
(i) such record relates to the
prescribing or dispensing of a substance use
disorder medication; and
``
(ii) such disclosure is required by
applicable State law.''.
<all>